Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities

Eli Lilly and Regeneron are among the first seven companies selected for the FDA's PreCheck Pilot Program, according to CNBC. The initiative streamlines approval of new manufacturing facilities by letting companies work with FDA reviewers early in the planning process.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton